binx health

binx health

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.mybinxhealth.com

Last Round

Series F

Apr 2, 2024

Total Funding Raised

$286.22M

Company Overview

Binx is a healthcare technology company that offers a point-of-care testing platform aimed at enhancing community well-being through rapid PCR-based diagnostics and a comprehensive digital program for testing, counseling, treatment, and follow-up.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine

Business Model

B2B2C

Customer Profile

Usage-Based SaaS, Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Keywords

point-of-care testingPOC testingmolecular diagnosticsrapid STI testingCT/NG testingtest-and-treatCLIA-waived testSTD testingdiagnostic instrumentsingle visit treatmentchlamydia testinggonorrhea testingpoint-of-care platformdiagnostic cartridgesreagent rental program

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

binx health Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

binx health Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series FApr 2, 2024
Series EMay 27, 2021
GrantAug 17, 2017
Series DJan 23, 2017
GrantMar 15, 2016
Series C
Jan 29, 2015

Key People

Founding team and executive leadership

Jack Crowley

Chief Financial Officer

Executive Team

Anna Dixon

Chief Operating Officer

Executive Team

binx health Investors

Notable investors and investment history

InvestorRounds
Innovate UKGrant
Technology Venture PartnersSeries D, Series C
Alta Life SciencesSeries E
EQT Life SciencesSeries F, Series C, Series B Extension, Series E, Series B, Series D
UK governmentGrant
HildredSeries E, Series F
RMI PartnersSeries D, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 22, 2026

    FDA-cleared and CLIA-Waived point-of-care platform for STI testing.

binx health Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

binx health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about binx health's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range92
Year Founded2005
Last FundingApr 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.